Evaluation of Breast Reduction Techniques

December 6, 2024 updated by: Herman Houin, MD, Henry Ford Health System

Breast Reductions: Retrospective Evaluation of Suction Assisted Breast Reduction with Peri-Areolar Mastopexy Compared to Longer Incision Pedicle Breast Reduction Techniques

The purpose of this study is to retrospectively evaluate breast reduction techniques in terms of complications, functionality, patient satisfaction, and cosmetic outcomes.

Study Overview

Status

Recruiting

Conditions

Detailed Description

A breast reduction is a common operation with a fairly high complication rate as large incision techniques require undermined skin flaps to be closed under tension. This study is evaluation the open incision breast reduction technique to a liposuction assisted breast reduction. This study will evaluate these two breast reduction techniques in terms of complication rates, functionality, patient satisfaction, and cosmetic outcomes. Participants will be asked to complete the BREAST-Q survey regarding their breast reduction postoperatively.

Study Type

Observational

Enrollment (Estimated)

490

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Detroit, Michigan, United States, 48202
        • Recruiting
        • Henry Ford Health System
        • Contact:
          • Herman Houin, MD
          • Phone Number: 313-916-2378

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Patients who underwent a breast reduction between 2013 and 2019.

Description

Inclusion Criteria:

  • Patients who underwent a breast reduction between 2013 and 2019
  • All patients who underwent a liposuction assisted or layered skin incision pedicled technique breast reduction.

Exclusion Criteria:

  • Patients who underwent additional procedures simultaneously at the time of the breast reduction.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Liposuction Assisted Breast Reduction
Open Incision Breast Reduction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Complication Rate
Time Frame: Postoperative Period (Average of 1 year following surgery)
To determine if liposuction assisted breast reduction has a lower postoperative complication rate as opposed to open incision breast reduction
Postoperative Period (Average of 1 year following surgery)
Breast Reduction Success Rate
Time Frame: Postoperative Period (Average of 1 year following surgery)
To determine if liposuction assisted breast reduction has a higher success rate as opposed to open incision breast reduction based on postoperative outcomes.
Postoperative Period (Average of 1 year following surgery)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 8, 2012

Primary Completion (Estimated)

December 12, 2025

Study Completion (Estimated)

June 12, 2026

Study Registration Dates

First Submitted

June 12, 2020

First Submitted That Met QC Criteria

August 10, 2020

First Posted (Actual)

August 11, 2020

Study Record Updates

Last Update Posted (Estimated)

December 11, 2024

Last Update Submitted That Met QC Criteria

December 6, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 7372

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Reductions

Subscribe